Annual Drug Patent Expirations for LONHALA+MAGNAIR+KIT
Lonhala Magnair Kit is a drug marketed by Sunovion Resp and is included in one NDA. It is available from two suppliers. There are eleven patents protecting this drug.
This drug has seventy-nine patent family members in thirteen countries.
The generic ingredient in LONHALA MAGNAIR KIT is glycopyrrolate. Two suppliers are listed for this compound. Additional details are available on the glycopyrrolate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
